# Ascendis Pharma (ASND) — Analyst Forecast

ASND · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/asnd/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | UBS | Initiated Coverage | Buy | $269.00 |
| Sep 25, 2026 | Cantor Fitzgerald | Maintained | Overweight | $300.00 |
| Sep 15, 2026 | Raymond James | Downgraded | Strong Buy → Outperform | $287.00 |
| Sep 2, 2026 | Oppenheimer | Maintained | Outperform | $312.00 |
| Sep 1, 2026 | Wedbush | Maintained | Outperform | $327.00 |
| Sep 1, 2026 | Morgan Stanley | Maintained | Overweight | $273.00 |
| Aug 31, 2026 | HC Wainwright & Co. | Maintained | Buy | $344.00 |
| Aug 31, 2026 | Stifel | Maintained | Buy | $326.00 |
| Aug 31, 2026 | B of A Securities | Maintained | Buy | $304.00 |
| Aug 31, 2026 | Jefferies | Maintained | Buy | $330.00 |
| Aug 27, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $345.00 |
| Aug 19, 2026 | BMO Capital | Initiated Coverage | Outperform | $319.00 |
| Aug 14, 2026 | Barclays | Maintained | Overweight | $329.00 |
| Aug 14, 2026 | RBC Capital | Maintained | Outperform | $290.00 |
| Aug 14, 2026 | TD Cowen | Maintained | Buy | $341.00 |
| Jul 23, 2026 | Morgan Stanley | Maintained | Overweight | $275.00 |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | $280.00 |
| May 19, 2026 | Citigroup | Initiated Coverage | Buy | $355.00 |
| May 15, 2026 | Evercore ISI Group | Maintained | Outperform | $329.00 |
| May 11, 2026 | Barclays | Maintained | Overweight | $345.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ASND?

On Oct 15, 2026, UBS initiated coverage of Ascendis Pharma at Buy with a price target of $269.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).